Prelude Therapeutics Inc. (PRLD)
| Sector: | Health Care |
| Super Investor Stats: | |
| Ownership count: | 0 |
| Ownership rank: | -- |
| % of all portfolios: | 0% |
| |
| Total insider Buys/Sells last 6 months: |
| Transactions | Total |
| Buys |
15 |
$876,166 |
| Sells |
0 |
$0 |
|
Portfolio Manager |
% of portfolio |
Recent activity |
Shares |
Value |
Open Market Insider Buys
| Date Filed |
Reporting Name |
Relationship |
Trans. Date |
Shares |
Price $ |
Total Value $ |
| 27 Mar 2025 |
COMBS ANDREW |
Chief Chemistry Officer |
25 Mar 2025 |
100,000 |
0.69 |
69,250 |
| 27 Mar 2025 |
VADDI KRISHNA |
CEO |
25 Mar 2025 |
675,000 |
0.69 |
467,438 |
| 24 Mar 2025 |
VADDI KRISHNA |
CEO |
21 Mar 2025 |
15,000 |
0.73 |
10,959 |
| 24 Mar 2025 |
VADDI KRISHNA |
CEO |
20 Mar 2025 |
5,416 |
0.73 |
3,950 |
| 18 Mar 2025 |
VADDI KRISHNA |
CEO |
17 Mar 2025 |
9,106 |
0.75 |
6,829 |
| 18 Mar 2025 |
VADDI KRISHNA |
CEO |
14 Mar 2025 |
29,999 |
0.75 |
22,631 |
| 14 Mar 2025 |
VADDI KRISHNA |
CEO |
13 Mar 2025 |
50,000 |
0.72 |
35,820 |
| 14 Mar 2025 |
VADDI KRISHNA |
CEO |
12 Mar 2025 |
47,500 |
0.71 |
33,744 |
| 03 Jan 2025 |
VADDI KRISHNA |
CEO |
31 Dec 2024 |
5,000 |
1.21 |
6,043 |
| 02 Jan 2025 |
VADDI KRISHNA |
CEO |
30 Dec 2024 |
10,000 |
1.20 |
12,000 |
| 26 Dec 2024 |
COMBS ANDREW |
Chief Chemistry Officer |
23 Dec 2024 |
60,000 |
1.37 |
82,002 |
| 26 Dec 2024 |
COMBS ANDREW |
Chief Chemistry Officer |
20 Dec 2024 |
3,075 |
1.15 |
3,536 |
| 20 Dec 2024 |
LIM BRYANT DAVID |
CLO, Interim CFO, Corp Sec. |
19 Dec 2024 |
25,000 |
0.91 |
22,638 |
| 20 Dec 2024 |
VADDI KRISHNA |
CEO |
19 Dec 2024 |
6,888 |
0.89 |
6,116 |
| 20 Dec 2024 |
VADDI KRISHNA |
CEO |
18 Dec 2024 |
100,000 |
0.93 |
93,210 |
| 26 May 2023 |
VADDI KRISHNA |
CEO |
25 May 2023 |
900 |
5.31 |
4,779 |
| 26 May 2023 |
VADDI KRISHNA |
CEO |
24 May 2023 |
1,000 |
5.01 |
5,011 |
| 25 May 2023 |
LIM BRYANT DAVID |
Chief Legal Officer, Corp Sec. |
24 May 2023 |
2,400 |
5.39 |
12,936 |
| 25 May 2023 |
CHARDONNET LAURENT |
Chief Financial Officer |
23 May 2023 |
5,000 |
5.50 |
27,500 |
| 25 May 2023 |
VADDI KRISHNA |
CEO |
23 May 2023 |
11,856 |
5.63 |
66,749 |
| 24 May 2023 |
ORBIMED ADVISORS LLC |
Director , 10% |
22 May 2023 |
869,565 |
5.75 |
4,999,999 |
| 21 Dec 2022 |
VADDI KRISHNA |
CEO |
20 Dec 2022 |
19,188 |
5.13 |
98,446 |
| 12 Dec 2022 |
CHARDONNET LAURENT |
Chief Financial Officer |
08 Dec 2022 |
10,000 |
4.76 |
47,600 |
* "Hold Price" is the last known price at which an investor still held a security. It is the closing price of the security as of the portfolio date (quarter end). This value is only provided when a security is owned by at least two investors. In the case of reporting dates being different, a weighted average price is calculated.
P = Preferred Stock